Monsanto Co. is the industry giant when it comes to creating, patenting and selling genetically modified (GM) seeds and associated chemicals such as the herbicide Roundup. Most of Monsanto’s sales are in the U.S. market, where there is no legal obligation to label GM ingredients as such. And this has played to Monsanto’s advantage. The company’s stock has performed ridiculously well over the last decade. It’s up about tenfold in 10 years. That’s the kind of gain people don’t complain about.
But there is a battle raging between consumers and Monsanto. I don’t have enough space in this article to dive into the science, but suffice to say that many industry experts believe genetically modified crops negatively affect our health. This is leading to a big push for better labelling, so consumers know if they are buying genetically modified foods or not.
Read the full, original story here: Monsanto: A food stock with a bad aftertaste